Letter to the editor: Effect of diabetes medications and glycemic control on risk of HCC in patients with NAFLD

Hepatology. 2022 Aug;76(2):E48-E49. doi: 10.1002/hep.32504. Epub 2022 Apr 20.

Authors

Yibing Zhou^{1

2}, Weike Chu^{1

2}, Xue Wu^{1

2}, Hui Zhou^{1

2}, Bin Niu^{1

2}, Ze Chen^{1

2}, Yuqiang Mi^{2

3}, Ping Li^{2

3}

Affiliations

¹ Tianjin Research Institute of Liver Disease, Tianjin, China.
² School of graduates, Tianjin Medical Univercity, Tianjin, China.
³ Department of Hepatology, Tianjin City Second People's Hospital, Tianjin, China.

PMID: 35366349
DOI: 10.1002/hep.32504

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular* / etiology
Carcinoma, Hepatocellular* / prevention & control
Diabetes Mellitus*
Glycemic Control
Humans
Liver Cirrhosis
Liver Neoplasms* / prevention & control
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / drug therapy
Risk Factors